LVZPF
Price
$5.22
Change
+$1.79 (+52.19%)
Updated
Sep 11 closing price
Capitalization
4.42B
UPC
Price
$5.23
Change
-$0.22 (-4.04%)
Updated
Oct 17 closing price
Capitalization
2.95M
Interact to see
Advertisement

LVZPF vs UPC

Header iconLVZPF vs UPC Comparison
Open Charts LVZPF vs UPCBanner chart's image
Livzon Pharmaceutical Group
Price$5.22
Change+$1.79 (+52.19%)
Volume$100
Capitalization4.42B
Universe Pharmaceuticals
Price$5.23
Change-$0.22 (-4.04%)
Volume$50.72K
Capitalization2.95M
LVZPF vs UPC Comparison Chart in %
LVZPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UPC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LVZPF vs. UPC commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LVZPF is a Hold and UPC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (LVZPF: $5.22 vs. UPC: $5.23)
Brand notoriety: LVZPF and UPC are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: LVZPF: 18% vs. UPC: 8%
Market capitalization -- LVZPF: $4.42B vs. UPC: $2.95M
LVZPF [@Pharmaceuticals: Generic] is valued at $4.42B. UPC’s [@Pharmaceuticals: Generic] market capitalization is $2.95M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.85B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.96B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LVZPF’s FA Score shows that 3 FA rating(s) are green whileUPC’s FA Score has 1 green FA rating(s).

  • LVZPF’s FA Score: 3 green, 2 red.
  • UPC’s FA Score: 1 green, 4 red.
According to our system of comparison, LVZPF is a better buy in the long-term than UPC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LVZPF’s TA Score shows that 0 TA indicator(s) are bullish while UPC’s TA Score has 3 bullish TA indicator(s).

  • LVZPF’s TA Score: 0 bullish, 1 bearish.
  • UPC’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, LVZPF is a better buy in the short-term than UPC.

Price Growth

LVZPF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while UPC (@Pharmaceuticals: Generic) price change was -22.06% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.79%. For the same industry, the average monthly price growth was +4.23%, and the average quarterly price growth was +51.45%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.79% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LVZPF($4.42B) has a higher market cap than UPC($2.95M). LVZPF YTD gains are higher at: 52.187 vs. UPC (-78.566). LVZPF has higher annual earnings (EBITDA): 3.68B vs. UPC (-15.83M). LVZPF has more cash in the bank: 10.6B vs. UPC (8.86M). UPC has less debt than LVZPF: UPC (6.51M) vs LVZPF (3.62B). LVZPF has higher revenues than UPC: LVZPF (11.8B) vs UPC (26.7M).
LVZPFUPCLVZPF / UPC
Capitalization4.42B2.95M149,966%
EBITDA3.68B-15.83M-23,278%
Gain YTD52.187-78.566-66%
P/E Ratio15.50N/A-
Revenue11.8B26.7M44,195%
Total Cash10.6B8.86M119,612%
Total Debt3.62B6.51M55,615%
FUNDAMENTALS RATINGS
LVZPF: Fundamental Ratings
LVZPF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
31
SMR RATING
1..100
53
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
20
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LVZPFUPC
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
N/A
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
17%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
8%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
8%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
LVZPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UPC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HNNA10.070.02
+0.17%
Hennessy Advisors
KN23.44-0.13
-0.55%
KNOWLES Corp
HII280.02-2.64
-0.93%
Huntington Ingalls Industries
WRN2.16-0.31
-12.55%
Western Copper and Gold Corp
NIVF1.23-0.80
-39.26%
NewGenIvf Group Limited

LVZPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, LVZPF has been loosely correlated with LIFD. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if LVZPF jumps, then LIFD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LVZPF
1D Price
Change %
LVZPF100%
N/A
LIFD - LVZPF
34%
Loosely correlated
+8.00%
UPC - LVZPF
8%
Poorly correlated
-4.04%
CLCFF - LVZPF
6%
Poorly correlated
N/A
AAWH - LVZPF
2%
Poorly correlated
-0.01%
VRNOF - LVZPF
2%
Poorly correlated
-3.38%
More

UPC and

Correlation & Price change

A.I.dvisor indicates that over the last year, UPC has been loosely correlated with BIOA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if UPC jumps, then BIOA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UPC
1D Price
Change %
UPC100%
-4.04%
BIOA - UPC
43%
Loosely correlated
+1.37%
TXMD - UPC
22%
Poorly correlated
+19.62%
CRON - UPC
13%
Poorly correlated
+0.40%
ASRT - UPC
13%
Poorly correlated
-2.90%
CGC - UPC
12%
Poorly correlated
-2.96%
More